India Ebitda from 2010 to 2024

INDIAGLYCO   1,359  29.50  2.22%   
India Glycols EBITDA yearly trend continues to be quite stable with very little volatility. The value of EBITDA is projected to decrease to about 3.1 B. From the period between 2010 and 2024, India Glycols, EBITDA regression line of its data series had standard deviation of  1,116,794,115 and standard deviation of  1,116,794,115. View All Fundamentals
 
EBITDA  
First Reported
2018-06-30
Previous Quarter
1.3 B
Current Value
1.3 B
Quarterly Volatility
241.5 M
 
Covid
Check India Glycols financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among India Glycols' main balance sheet or income statement drivers, such as Depreciation And Amortization of 869.6 M, Interest Expense of 751.4 M or Total Revenue of 25.7 B, as well as many indicators such as . India financial statements analysis is a perfect complement when working with India Glycols Valuation or Volatility modules.
  
This module can also supplement various India Glycols Technical models . Check out the analysis of India Glycols Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in India Stock

India Glycols financial ratios help investors to determine whether India Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in India with respect to the benefits of owning India Glycols security.